{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:26:26Z","timestamp":1791267986266,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","pediatric.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.pcl.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:45:45Z","timestamp":1469526345000},"page":"637-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Respiratory System Disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Danielle M.","family":"Goetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet"},{"issue":"11","key":"10.1016\/j.pcl.2016.04.007_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/archdischild-2013-304400","article-title":"Recent advances in the management of cystic fibrosis","volume":"99","author":"Davies","year":"2014","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-2600(13)70026-2","article-title":"Early lung disease in cystic fibrosis","volume":"1","author":"Grasemann","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"16","key":"10.1016\/j.pcl.2016.04.007_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc1502191","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/rccm.201504-0656UP","article-title":"Update in cystic fibrosis 2014","volume":"192","author":"Ong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 40","key":"10.1016\/j.pcl.2016.04.007_bib6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/ppul.23247","article-title":"CFTR, bicarbonate, and the pathophysiology of cystic fibrosis","volume":"50","author":"Borowitz","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"133","key":"10.1016\/j.pcl.2016.04.007_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1183\/09059180.00006113","article-title":"Current concepts: host-pathogen interactions in cystic fibrosis airways disease","volume":"23","author":"Tang","year":"2014","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pcl.2016.04.007_bib8","unstructured":"CF Foundation (CFF). 2014 patient registry annual data report. 2014. Available at: https:\/\/www.cff.org\/About-Us\/Assets\/2014-Annual-Report. Accessed November 15, 2015."},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1513\/AnnalsATS.201309-303OC","article-title":"Risk factors for the progression of cystic fibrosis lung disease throughout childhood","volume":"11","author":"Sanders","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"14","key":"10.1016\/j.pcl.2016.04.007_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa051469","article-title":"Genetic modifiers of lung disease in cystic fibrosis","volume":"353","author":"Drumm","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.pcl.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ppul.23217","article-title":"Risk factors for lung function decline in a large cohort of young cystic fibrosis patients","volume":"50","author":"Cogen","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"10.1016\/j.pcl.2016.04.007_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1089\/jwh.2014.4985","article-title":"Gender differences in outcomes of patients with cystic fibrosis","volume":"23","author":"Harness-Brumley","year":"2014","journal-title":"J\u00a0Womens Health (Larchmt)"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1378\/chest.14-2189","article-title":"Assessing differences in mortality rates and risk factors between Hispanic and non-Hispanic patients with cystic fibrosis in California","volume":"149","author":"Buu","year":"2016","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.pcl.2016.04.007_bib16","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1164\/rccm.201307-1268OC","article-title":"Air trapping and airflow obstruction in newborn cystic fibrosis piglets","volume":"188","author":"Adam","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6198","key":"10.1016\/j.pcl.2016.04.007_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1255825","article-title":"Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis","volume":"345","author":"Hoegger","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.201011-1892OC","article-title":"Infection, inflammation, and lung function decline in infants with cystic fibrosis","volume":"184","author":"Pillarisetti","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","article-title":"Progression of early structural lung disease in young children with cystic fibrosis assessed using CT","volume":"67","author":"Mott","year":"2012","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","article-title":"Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening","volume":"180","author":"Sly","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.007_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/thoraxjnl-2013-204176","article-title":"Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?","volume":"69","author":"Thia","year":"2014","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/thx.2005.045146","article-title":"Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis","volume":"61","author":"de Jong","year":"2006","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.pcl.2016.04.007_bib24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thoraxjnl-2012-201747","article-title":"Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening","volume":"67","author":"Hoo","year":"2012","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib25","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"4 Pt 1","key":"10.1016\/j.pcl.2016.04.007_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","article-title":"Lower airway inflammation in infants and young children with cystic fibrosis","volume":"156","author":"Armstrong","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3 Suppl","key":"10.1016\/j.pcl.2016.04.007_bib27","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpeds.2005.08.034","article-title":"Complications associated with symptomatic diagnosis in infants with cystic fibrosis","volume":"147","author":"Accurso","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2016.04.007_bib28","series-title":"Nelson textbook of pediatrics","first-page":"1803","article-title":"Cystic fibrosis","author":"Boat","year":"2008"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOO.0000000000000014","article-title":"What is the optimal management of chronic rhinosinusitis in cystic fibrosis?","volume":"22","author":"Crosby","year":"2014","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2016.04.007_bib30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1569-1993(13)00150-1","article-title":"Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis","volume":"12","author":"Aanaes","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3 Suppl","key":"10.1016\/j.pcl.2016.04.007_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.otohns.2007.06.726","article-title":"Clinical practice guideline: adult sinusitis","volume":"137","author":"Rosenfeld","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/1573396309666131209205748","article-title":"Rhinosinusitis in the pediatric patient with cystic fibrosis","volume":"10","author":"Fundakowski","year":"2014","journal-title":"Curr Pediatr Rev"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.007_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2500\/108854196778662246","article-title":"Epidemiology of nasal polyps","volume":"17","author":"Settipane","year":"1996","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.otohns.2006.01.027","article-title":"Management of recurrent sinus disease in children with cystic fibrosis: a combined approach","volume":"135","author":"Shatz","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/10906570152742317","article-title":"A\u00a0pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes","volume":"5","author":"Castellani","year":"2001","journal-title":"Genet Test"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archotol.131.3.237","article-title":"Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation","volume":"131","author":"Wang","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3476(97)70025-8","article-title":"Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis","volume":"131","author":"Corey","year":"1997","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/thx.2005.043372","article-title":"Improving rate of decline of FEV1 in young adults with cystic fibrosis","volume":"61","author":"Que","year":"2006","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1164\/rccm.200911-1646OC","article-title":"Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis","volume":"183","author":"Aurora","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/resp.12329","article-title":"Interpretation of lung function in infants and young children with cystic fibrosis","volume":"19","author":"Ramsey","year":"2014","journal-title":"Respirology"},{"issue":"21","key":"10.1016\/j.pcl.2016.04.007_bib42","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/jama.2012.5214","article-title":"Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial","volume":"307","author":"Rosenfeld","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib43","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jcf.2013.04.005","article-title":"Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European cystic fibrosis patient registry, 2007-2009","volume":"12","author":"VanDevanter","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib44","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1513\/AnnalsATS.201301-017ST","article-title":"An official American thoracic society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age","volume":"10","author":"Rosenfeld","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1378\/chest.06-1351","article-title":"Spirometry in early childhood in cystic fibrosis patients","volume":"131","author":"Vilozni","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1164\/rccm.200710-1599OC","article-title":"Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis","volume":"178","author":"Kozlowska","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ppul.21589","article-title":"Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting","volume":"47","author":"Kerby","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.pcl.2016.04.007_bib48","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3109\/02770903.2010.485664","article-title":"Clinically useful spirometry in preschool-aged children: evaluation of the 2007 American thoracic society guidelines","volume":"47","author":"Gaffin","year":"2010","journal-title":"J\u00a0Asthma"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2013.09.005","article-title":"Lung clearance index: evidence for use in clinical trials in cystic fibrosis","volume":"13","author":"Kent","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib50","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1513\/AnnalsATS.201501-021FR","article-title":"Multiple-breath washout as a lung function test in cystic fibrosis. A cystic fibrosis foundation workshop report","volume":"12","author":"Subbarao","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1164\/rccm.200407-895OC","article-title":"Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis","volume":"171","author":"Aurora","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.007_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/thx.2009.125831","article-title":"Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function","volume":"65","author":"Amin","year":"2010","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1183\/09031936.00072510","article-title":"The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis","volume":"37","author":"Amin","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcl.2016.04.007_bib54","first-page":"350","article-title":"Lung clearance index as an endpoint in a multicenter randomized control trial of ivacaftor in subjects with cystic fibrosis who have mild lung disease","volume":"47","author":"Ratjen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.pcl.2016.04.007_bib55","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2010.06.010","article-title":"Sensitivity of lung clearance Index and chest computed tomography in early CF lung disease","volume":"104","author":"Ellemunter","year":"2010","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.2007.077784","article-title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","volume":"63","author":"Gustafsson","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/thx.2010.150375","article-title":"Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF","volume":"66","author":"Owens","year":"2011","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thoraxjnl-2013-203807","article-title":"Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis","volume":"69","author":"Vermeulen","year":"2014","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib59","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thoraxjnl-2012-202538","article-title":"Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation","volume":"68","author":"Horsley","year":"2013","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/(SICI)1099-0496(200006)29:6<457::AID-PPUL8>3.0.CO;2-9","article-title":"Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies","volume":"29","author":"Koscik","year":"2000","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1542\/peds.63.1.24","article-title":"The chest roentgenogram in cystic fibrosis: a new scoring system","volume":"63","author":"Brasfield","year":"1979","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.pcl.2016.04.007_bib62","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s002470050684","article-title":"High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate","volume":"29","author":"Brody","year":"1999","journal-title":"Pediatr Radiol"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib63","first-page":"711","article-title":"The impact of treatment of pulmonary exacerbations on the health-related quality of life of patients with cystic fibrosis: does hospitalization make a difference?","volume":"144","author":"Yi","year":"2004","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2016.04.007_bib64","unstructured":"CF Foundation (CFF). Treatment of pulmonary exacerbations of cystic fibrosis. Clinical practice guidelines for cystic fibrosis. Bethesda (MD): 1997."},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib65","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ejrad.2011.02.045","article-title":"Morphologic and functional scoring of cystic fibrosis lung disease using MRI","volume":"81","author":"Eichinger","year":"2012","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.pcl.2016.04.007_bib66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielputz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2011.954","article-title":"Effect of bronchoalveolar lavage-directed therapy on pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial","volume":"306","author":"Wainwright","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jpeds.2014.05.031","article-title":"Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis","volume":"165","author":"Moodie","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.121.1.64","article-title":"Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis","volume":"121","author":"Britto","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/thx.2006.060905","article-title":"Exacerbations in cystic fibrosis: 3\u2013management","volume":"63","author":"Smyth","year":"2008","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(94)70301-9","article-title":"Outcome measures for clinical trials in cystic fibrosis. Summary of a cystic fibrosis foundation consensus conference","volume":"124","author":"Ramsey","year":"1994","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.pcl.2016.04.007_bib73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.2401009","article-title":"Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!","volume":"169","author":"Marshall","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib74","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.pcl.2016.04.007_bib76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib77","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jpeds.2005.10.019","article-title":"Cystic fibrosis pulmonary exacerbations","volume":"148","author":"Ferkol","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.007_bib78","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ppul.20023","article-title":"Pulmonary exacerbations in cystic fibrosis","volume":"37","author":"Rabin","year":"2004","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mpd.2001.117288","article-title":"Defining a pulmonary exacerbation in cystic fibrosis","volume":"139","author":"Rosenfeld","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib80","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ppul.1072","article-title":"Defining an exacerbation of pulmonary disease in cystic fibrosis","volume":"31","author":"Dakin","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 40","key":"10.1016\/j.pcl.2016.04.007_bib81","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ppul.23266","article-title":"Respiratory tract exacerbations revisited: ventilation, inflammation, perfusion, and structure (VIPS) monitoring to redefine treatment","volume":"50","author":"Tiddens","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.pcl.2016.04.007_bib82","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Pt 1","key":"10.1016\/j.pcl.2016.04.007_bib83","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-3476(87)80217-2","article-title":"Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis","volume":"111","author":"Gold","year":"1987","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.pcl.2016.04.007_bib84","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archpedi.1980.02130240018007","article-title":"Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy","volume":"134","author":"Wientzen","year":"1980","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib85","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1183\/09031936.97.10040896","article-title":"Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects","volume":"10","author":"Wolter","year":"1997","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib86","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1099-0496(199707)24:1<42::AID-PPUL7>3.0.CO;2-L","article-title":"Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis","volume":"24","author":"Bosworth","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.pcl.2016.04.007_bib87","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ppul.20433","article-title":"Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis","volume":"41","author":"Nazer","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib88","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thx.2003.005876","article-title":"Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis","volume":"59","author":"Thornton","year":"2004","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib89","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3476(99)70197-6","article-title":"Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis","volume":"134","author":"Smith","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.007_bib90","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1378\/chest.123.5.1495","article-title":"Susceptibility testing of pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis","volume":"123","author":"Smith","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pcl.2016.04.007_bib91","series-title":"Hodson and Geddes cystic fibrosis","first-page":"221","article-title":"Pulmonary exacerbations","author":"Flume","year":"2016"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib92","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur Respir J"},{"issue":"7027","key":"10.1016\/j.pcl.2016.04.007_bib93","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","article-title":"Single or multiple daily doses of aminoglycosides: a meta-analysis","volume":"312","author":"Barza","year":"1996","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.007_bib94","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1592\/phco.19.8.620.31525","article-title":"A\u00a0pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis","volume":"19","author":"Bosso","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib95","first-page":"522","article-title":"Cystic fibrosis pulmonary guidelines: airway clearance therapies","volume":"54","author":"Flume","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.pcl.2016.04.007_bib96","first-page":"132","article-title":"Comparative trial of positive expiratory pressure, autogenic drainage and conventional percussion and drainage techniques (abstract)","volume":"5","author":"Davidson","year":"1988","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib97","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.108.4.952","article-title":"Short-term effects of postural drainage with clapping vs autogenic drainage on oxygen saturation and sputum recovery in patients with cystic fibrosis","volume":"108","author":"Giles","year":"1995","journal-title":"Chest"},{"issue":"5 Pt 1","key":"10.1016\/j.pcl.2016.04.007_bib98","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(05)81356-3","article-title":"Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis","volume":"124","author":"Konstan","year":"1994","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib99","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1099-0496(199610)22:4<271::AID-PPUL7>3.0.CO;2-P","article-title":"A\u00a0comparison of bronchial drainage treatments in cystic fibrosis","volume":"22","author":"Kluft","year":"1996","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib100","first-page":"470","article-title":"Comparison of expectorated sputum after manual chest physical therapy and high-frequency chest compression","volume":"38","author":"Warwick","year":"2004","journal-title":"Biomed Instrum Technol"},{"key":"10.1016\/j.pcl.2016.04.007_bib101","first-page":"A738","article-title":"A\u00a0direct comparison of manual chest percussion with acoustic percussion, an experimental treatment for cystic fibrosis [abstract]","volume":"151","author":"Kraig","year":"1995","journal-title":"Am J Respir Crit Care Med Suppl"},{"issue":"8","key":"10.1016\/j.pcl.2016.04.007_bib102","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ptj\/69.8.633","article-title":"Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis","volume":"69","author":"Cerny","year":"1989","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2011.10.003","article-title":"Effect of dornase alfa on inflammation and lung function: potential role in the early treatment of cystic fibrosis","volume":"11","author":"Konstan","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib104","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/rccm.2110015","article-title":"Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis","volume":"166","author":"Suri","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1067\/mpd.2001.118570","article-title":"A\u00a0two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities","volume":"139","author":"Quan","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib106","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ppul.21388","article-title":"Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis","volume":"46","author":"Konstan","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib107","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1542\/peds.2005-0308","article-title":"A\u00a0crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis","volume":"116","author":"Fitzgerald","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib108","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1378\/chest.14-1997","article-title":"The evolution of cystic fibrosis care","volume":"148","author":"Pittman","year":"2015","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.pcl.2016.04.007_bib109","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/thx.52.10.900","article-title":"Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis","volume":"52","author":"Robinson","year":"1997","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A\u00a0controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M","article-title":"Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis","volume":"21","author":"Eng","year":"1996","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001506.pub2","article-title":"Nebulised hypertonic saline for cystic fibrosis","author":"Wark","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pcl.2016.04.007_bib113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.1999.tb01265.x","article-title":"Systematic review of N-acetylcysteine in cystic fibrosis","volume":"88","author":"Duijvestijn","year":"1999","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib114","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MCP.0b013e32831311e8","article-title":"Ibuprofen therapy for cystic fibrosis lung disease: revisited","volume":"14","author":"Konstan","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"10.1016\/j.pcl.2016.04.007_bib115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archpediatrics.2011.136","article-title":"Comparative efficacy and safety of 4 randomized regimens to treat early pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"165","author":"Treggiari","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"9","key":"10.1016\/j.pcl.2016.04.007_bib116","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1517\/14656566.2013.790366","article-title":"Inhaled antibiotics for the treatment of chronic bronchopulmonary pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials","volume":"14","author":"Maiz","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib117","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1378\/chest.128.2.729","article-title":"Massive hemoptysis in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib118","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1569-1993(03)00066-3","article-title":"Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study","volume":"2","author":"Barben","year":"2003","journal-title":"J\u00a0Cyst Fibros"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.007_bib119","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.prrv.2012.01.003","article-title":"Cystic fibrosis: management of haemoptysis","volume":"13","author":"Hurt","year":"2012","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ppul.1950150311","article-title":"Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis","volume":"15","author":"Schidlow","year":"1993","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.007_bib121","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2016.04.007_bib122","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/thx.2010.136986","article-title":"Management of spontaneous pneumothorax: British thoracic society pleural disease guideline 2010","volume":"65","author":"MacDuff","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pcl.2016.04.007_bib123","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1378\/chest.128.2.720","article-title":"Pneumothorax in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"issue":"Suppl 3","key":"10.1016\/j.pcl.2016.04.007_bib124","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.pcl.2016.04.007_bib125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/MCP.0000000000000105","article-title":"What is the role of noninvasive ventilation in cystic fibrosis?","volume":"20","author":"Bright-Thomas","year":"2014","journal-title":"Curr Opin Pulm Med"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395516300153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395516300153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T10:03:27Z","timestamp":1692439407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395516300153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0031395516300153"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2016.04.007","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory System Disease","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}